Wandercraft acquires Ekso Bionics, combining Atalante X and EksoNR exoskeleton lines
Wandercraft announced on October 1, 2026 that it acquired Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN); terms were not disclosed and the deal signed and closed the same day. The release says Atalante X and EksoNR together are used at more than 700 rehabilitation centers worldwide, and Wandercraft intends to keep supporting both plus the Eve and Indego Personal home exoskeletons. It also notes that Medicare covers qualifying personal exoskeletons under the brace benefit category, billed under HCPCS code K1007, for individuals who meet eligibility and medical necessity requirements.
Why it matters. Rehab centers running either platform now have one vendor for service and clinical support, and one larger company advocating on K1007 reimbursement.
Sources
Get the digest by email
The email starts once enough readers ask for it. Until then every issue is published here each Monday morning.